Internal Medicine Comprehensive Review and Update 2026

  • Continuing Education
Blue stethoscope on table with blurred background

This program, the 66th annual Internal Medicine Comprehensive Review and Update from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital, provides comprehensive, high-yield instruction to ensure clinicians are current with the latest evidence and best practices to optimize patient care.

  • Live Online

This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat. 

 

Additionally, all sessions will be recorded and made available to participants for online viewing for 6 months after the end of the course--through December 30, 2026.

 

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits, up to the approved maximum. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

$1,495

This is the full tuition for physicians. A $100 early registration discount is available. 

 

For tuition for other medical professionals, please see the full table below. 

 

 

Early Registration Deadline:

Continuing Education Credits

Earn up to:


» 60.00 AMA PRA Category 1 Credits™

 

» 60.00 ABIM MOC points

 

» 60:00 AAFP Live Prescribed credits

 

» 60.00 ECME Credits®

 

View all

6 Days

This 6-day intensive program, which is among the highest-rated Harvard Medical School CME courses, updates busy clinicians on evidence-based best practices in internal medicine. 

 

See schedule below

On This Page

Overview

Comprehensive Updates, Strategies, and Practice Recommendations for State-of-the-Art Internal Medicine 

Internal Medicine Comprehensive Review and Update 2026 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies. 

This program, the 66th annual Internal Medicine Comprehensive Review and Update from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital, provides comprehensive, high-yield instruction to ensure clinicians are current with the latest evidence and best practices to optimize patient care.

This program covers the breadth of Internal Medicine subspecialties, including:

  • Cardiovascular Medicine
  • Hematology and Oncology, including CAR T-cell therapies
  • Immunotherapies and Biologics
  • Pulmonary and Critical Care Medicine
  • Infectious Diseases
  • Gastroenterology
  • Endocrinology
  • Rheumatology
  • Nephrology
  • Obesity Medicine
  • Women’s Health
  • Geriatrics
  • Hospital Medicine
  • Allergy and Immunology
  • Neurology
  • Psychiatry
  • Palliative Care
  • Pain Medicine

Practical, Results-Focused Education for Ambulatory and Inpatient Settings

Enhance your skills and optimize your patient outcomes by joining Harvard Medical School’s most distinguished faculty—across all relevant fields of Internal Medicine—as they provide updates, best practices, and clinical strategies designed to improve day-to-day practice in both ambulatory and inpatient settings.

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 6 months after the conclusion of the course--through December 30, 2026. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits, up to the approved maximum. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

Developed and Offered By:

  • Massachusetts General Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.

Participant Types

 

  • Internists
  • Family Physicians
  • Medical Specialists
  • Nurse Practitioners
  • Physician Assistants
  • ...and other medical professionals who want a comprehensive review of Internal Medicine and its subspecialties.

Schedule

This program is among the highest-rated Harvard Medical School CME courses. 

 

All schedule times are Eastern Daylight Time.

Please note that program changes / substitutions may be made without notice.

Day 1

Monday, June 1, 2026

Introduction

Drs. Rocío Hurtado and Jose Florez

7:00-7:15 am

Acute Kidney Injury: A Practical Framework

7:15-8:00 am

Venous Thromboembolic Disease: A Practical Approach

8:00-9:00 am

Giant Cell Arteritis and Polymyalgia Rheumatica: Novel Approaches

9:00-9:45 am

Break

9:45-10:15 am

Fever Syndromes in 2026 (Noninfectious)

10:15-11:00 am

Dysnatremias: A Practical Approach

11:00 am-12:00 pm

The Use of Opioids for Chronic Pain Management

12:00-12:45 pm

Break

12:45-1:15 pm

Systemic Lupus for the Clinician

1:15-1:45 pm

Update in Management of Chronic Kidney Disease, Including ESRD

1:45-2:30 pm

Demistifying Laboratory Interpretation in Rheumatology

2:30-3:00 pm

Inflammatory Arthritis Syndromes: What's New

3:00-3:30 pm

Hot Topics in Critical Care Nephrology

3:30-4:15 pm

Break

4:15-4:30 pm

Metabolic Health in 2026

Monday Workshop Option A

4:30 pm - 7:15 pm

Fatty Liver Disease: Key Concepts in Management

4:30-5:15 pm

Pharmacologic Management of Obesity in 2026

5:15-6:00 pm

Exercise for Health: What's New in 2026

6:00-6:45 pm

Q&A

6:45-7:15 pm

Addiction Medicine

Monday Workshop Option B

4:30 pm - 7:15 pm

Update in Opiate Use Disorder in in Clinical Practice

4:30-5:15 pm

Infections in Patients with Opiate Use Disorder

5:15-6:00 pm

Alcohol Use Disorder

6:00-6:45 pm

Q&A

6:45-7:15 pm

Day 2

Tuesday, June 2, 2026

Q & A with the Professors

7:00-7:30 am

Contemporary Diagnosis and Management of Hypertensive Disorders

7:30-8:15 am

Sepsis Update in 2026

8:15-9:00 am

Type 2 Diabetes: A Comprehensive Review for the Practicing Clinician

9:00-9:45 am

Break

9:45-10:00 am

Osteoporosis: A Practical Approach for 2026

10:00-10:45 am

New Frontiers in Tobacco Cessation 2026

10:45-11:30 am

Contemporary Management Strategies in Diabetes 2026

11:30 am-12:15 pm

Menopause in 2026: What to Know

12:15-12:45 pm

Break

12:45-1:30 pm

Hospital Medicine Update

1:30-2:15 pm

Allergy and Immunology Update

2:15-3:00 pm

What's New in Sleep Apnea

3:00-3:30 pm

Anemia and Other Hematology Cases: Interactive Session

3:30-4:15 pm

Break

4:15-4:30 pm

Asthma Diagnosis and Management in 2026

4:30-5:15 pm

Chronic Cough: How to Approach and How to Manage

5:15-6:00 pm

COPD in 2026

6:00-6:45 pm

Update on Ovarian and Cervical Cancer Screening: What's New in 2026

6:45-7:30 pm

Day 3

Wednesday, June 3, 2026

Q & A with the Professors

7:00-7:30 am

HIV/AIDS Update in 2026

7:30-8:15 am

COVID-19 in 2026: Lessons Learned and Key Management Strategies

8:15-9:00 am

Urinary Tract Infections: A Contemporary Approach to Diagnosis and Management

9:00-9:45 am

C. diff Update: Latest Concepts

9:45-10:30 am

Break

10:30-10:45 am

Cases in Critical Care Medicine in 2026

10:45-11:15 am

Thyroid Disorders in 2026

11:15 am-12:00 pm

Pneumonia: A Practical Approach in 2026

12:00-12:45 pm

CPC New England Journal of Medicine

12:45-1:45 pm

Break

1:45-2:30 pm

Skin/Soft Tissue Infections for the Clinician

2:30-3:15 pm

What's New in Immunizations for the Practicing Clinician: Navigating the Maze

3:15-4:00 pm

Break

4:00-4:15 pm

Common ENT and Respiratory Infections in Clinical Practice: What's New

4:15-5:00 pm

Infections in the Immunocompromised Host

5:00-5:30 pm

Antibiotics: What You Need to Know in 2026

5:30-6:15 pm

Update in Sexually Transmitted Diseases

6:15-7:15 pm

Day 4

Thursday, June 4, 2026

Q & A with the Professors

7:00-7:30 am

Breast Cancer Screening and Prevention in 2026

7:30-8:15 am

Breast Cancer Management: What's New in the Field

8:15-9:00 am

Coagulation I

9:00-9:45 am

Break

9:45-10:00 am

Coagulation II

10:00-10:45 am

What You Need to Know About Immunotherapies in Oncology

10:45-11:30 am

The Evolution of Obesity Care 2026

11:30 am-12:30 pm

Break

12:30-1:15 pm

Colon Cancer Screening Update in 2026

1:15-2:00 pm

Update in Prostate Cancer

2:00-2:30 pm

Viral Hepatitis

2:30-3:15 pm

Update in Gastroesophageal Reflux Disease and Irritable Bowel Syndrome

3:15-4:00 pm

Update in GI Malignancies in 2026

4:00-4:45 pm

Break

4:45-5:00 pm

New Frontiers in Hem/Onc 2026

Thursday Workshop Option A

5:00 pm - 7:45 pm

Car-T Cell Therapy for the Clinician: Nuts and Bolts

5:00-5:45 pm

New Frontiers in Rapid Cancer Screening in 2026

5:45-6:30 pm

Lifestyle and Cancer

6:30-7:15 pm

Q&A

7:15-7:45 pm

Key Advances in Cardiology in 2026

Thursday Workshop Option B

5:00 pm - 7:45 pm

Nutrition and Cardiac Disease: What the Clinician Needs to Know

5:00-5:45 pm

New Frontiers in Cardio-Oncology

5:45-6:30 pm

Hot Topics in Valvular Disease, Including Infective Endocarditis

6:30-7:15 pm

Q&A

7:15-7:45 pm

Day 5

Friday, June 5, 2026

Q & A with the Professors

7:00-7:30 am

Best Approaches in the Evaluation of Patients with CAD

7:30-8:15 am

Atrial Fibrillation and Ventricular Arrhythmias in 2026

8:15-9:00 am

Acute Coronary Syndrome in 2026

9:00-9:45 am

Break

9:45-10:00 am

Contemporary Approach to Heart Failure Management

10:00-10:45 am

Thoracic Aorta Disease Update

10:45-11:15 am

AI in Medicine: A New Frontier

11:15 am-12:00 pm

Break

12:00-12:30 pm

Q & A Session with Cardiology

12:30-1:15 pm

Hyperlipidemia: Latest Concepts

1:15-2:00 pm

Medical Management of CAD: What's New

2:00-2:45 pm

Lung Cancer Update

2:45-3:30 pm

Delirium in 2026: What the Clinician Needs to Know

3:30-4:00 pm

Break

4:00-4:15 pm

TB Update in 2026

4:15-4:45 pm

Contemporary Management in Cirrhosis

4:45-5:30 pm

Peripheral Arterial Disease: What You Need to Know

5:30-6:00 pm

Palliative Care Update

6:00-7:00 pm

Day 6

Saturday, June 6, 2026

Headaches and Stroke: Update for the Clinician

7:00-8:00 am

Cases in Geriatrics: Pearls for the Practicing Clinician

8:00-8:45 am

Update on Depression and Anxiety in 2026

8:45-9:45 am

Break

9:45 am-10:15 am

New Frontiers in Dementia: Updates and Clinical Pearls

10:15-11:15 am

Heart Disease in Women in 2026

11:15 am-12:00 pm

2026 Program Highlights

Highlights of the 2026 program, comprising 80+ high-impact, incisive educational sessions, include:

  • Comprehensive updates across all areas of Internal Medicine presented by Harvard Medical School’s leading clinical faculty and most distinguished teachers
  • Specific evidence-based recommendations to incorporate updates into practice for optimized patient care and outcomes
  • AI in health care
  • Outcomes-driven strategies to improve diagnosis and management of diseases seen in both ambulatory and inpatient settings
  • Case-based sessions and daily Q&A sessions with Harvard faculty
  • New in 2026: Workshops spanning advances in Cardiology, Hematology-Oncology, Addiction Medicine, and Metabolic Health
  • Expanded treatment options for:
    • Cardiovascular disease (including CVD in women and preventive Cardiology)
    • Obesity (including novel medical therapies and lifestyle management)
    • Diabetes and novel therapeutic strategies
    • Women’s health
    • COPD, asthma, and obstructive sleep apnea
    • Smoking cessation
    • GERD, functional bowel disorders, and upper tract diseases
    • Vasculitis, SLE, rheumatoid arthritis, and more
    • Cirrhosis and metabolic dysfunction-associated steatotic liver disease (MASLD)
  • The state of the art in:
    • Coronary artery disease screening
    • Acute coronary syndrome management
    • Anticoagulation strategies
    • Management of obesity and metabolic health
    • Lifestyle and cancer
    • Delirium and dementia and updated management strategies
    • Thromboembolic disease and its complications
    • Immunotherapies in Hematology-Oncology
    • Cancer screening strategies (including novel rapid diagnostics)
    • Contemporary management of pneumonia
    • HIV medicine, care of the immunosuppressed host, and skin/soft tissue infections
    • Management of C. difficile (including new therapies)
    • Immunization strategies and updates
    • Diagnostic and treatment strategies for viral hepatitis
    • Acute kidney injury and care of patients with chronic kidney disease
    • Management of urinary tract infections—new 2025 guidelines
    • Osteoporosis management and approach to the patient with menopausal symptoms
    • Diagnosis and management of anxiety and depression  
  • The latest guidelines for:
    • Breast cancer, ovarian cancer, prostate cancer, and colon cancer screening
    • Hyperlipidemia and hypertension
    • Diagnosis and management of sepsis
    • UTI management
    • Rational antibiotic use in the era of rising antimicrobial resistance  
  • A live, interactive New England Journal of Medicine (NEJM) Clinicopathologic Conference (CPC) session
Distance Learning Workshops
  • Metabolic Health in 2026
  • Addiction Medicine
  • New Frontiers in Hematology-Oncology
  • Key Advances in Cardiology in 2026

Practice-Changing Education

Past participants report that this course has inspired and changed their practice.

CLICK HERE to hear how. 

Optimized for Remote Education

The 2026 program has been enhanced for distance learning:

  • Live streamed sessions
  • Q&A with the Professors
  • Recordings of all live streamed education made available to participants for online viewing, at your convenience, through December 30, 2026.
    • Easy access to these recordings will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them.
    • In addition, participants can review sessions previously watched via live stream to reinforce key learning points.
    • All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits, up to the approved maximum.  (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Live Stream

Learning Objectives

Upon completion of this course, participants will be able to:

  • Apply the most up-to-date and evidence-based recommendations for diagnosis and clinical management of the most relevant illnesses seen across Internal Medicine.
  • Incorporate new clinical and translational research findings across Internal Medicine and its subspecialties into more effective approaches in medical management across a wide array of clinical settings (ambulatory and inpatient).
  • Identify the full the breadth and depth of diagnostic and management strategies used in everyday clinical practice as guided by the medical literature with the aim to improve patient outcomes.

Faculty

 

Course Directors

2026 faculty list coming soon. 

2026 faculty list coming soon. 

Course Fees

Fee Disclaimer

Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. 

Please review the cancellation policy.

Early Registration Deadline:

Role Course Fee Early Registration Course Fee
Physician (MD/DO) $1,495.00 $1,395.00
Nurse (RN/APRN) $1,395.00 $1,295.00
PA $1,395.00 $1,295.00
Resident/Fellow $1,395.00 $1,295.00
Allied Health Professional / Other $1,395.00 $1,295.00

All registrants of Internal Medicine Comprehensive Review and Update will receive an electronic syllabus.

All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available through December 30, 2026.

Click Here to Register

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Harvard Medical School designates this live activity for a maximum of 60.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 60.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

The AAFP has reviewed Internal Medicine Comprehensive Review and Update 2026 and deemed it acceptable for up to 60.00 Live AAFP Prescribed credit(s). Term of Approval is from 06/01/2026 to 06/06/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 6.00 credits of Risk Management Study. This includes:

  • 2.00 credits of Opioid Education and Pain Management Training
  • 1.75 credits of End-of-Life Care Education

Please check your individual state licensing board requirements before claiming these credits.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

Program Topics